Fujifilm to Demonstrate Advances in AI Utilization, Speed and Automation in Enterprise Imaging Workflows at RSNA 2025

LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, will showcase new innovations in its industry leading Synapse medical informatics portfolio at the 2025 Radiological Society of North America (RSNA) Conference & Annual Meeting held November 30 to December 3. The new innovations in booth #3300 include a comprehensive enterprise imaging and informatics solution designed to meet the demands of outpatient imaging centers, and updates to Fujifilm’s flagship Synapse Enterprise PACS.

“Our customers are some of the world’s largest health systems and outpatient practices, and Fujifilm is steadfast in its commitment to deliver new innovative enterprise imaging technology which aligns with the needs of our global provider partners,” said Bill Lacy, senior vice president, medical informatics global business, FUJIFILM Healthcare Americas Corporation. “At this year’s RSNA, we’re shining a light on the continuous expansion of our Synapse enterprise imaging portfolio, and we are extremely excited to demonstrate the next generation of our cloud first Synapse PACS with native advanced visualization and AI adoption from imaging analytics to AI driven workflow.”

Fujifilm’s new medical informatics solutions that will be showcased at booth #3300 include:

• Synapse PACS: Attendees will have the opportunity to demo Fujifilm’s flagship PACS which now embeds artificial intelligence and 3D advanced visualization applications, bringing automated study assignments and prioritization along with 3D-enhanced image analyses directly within the reader’s workflow. Synapse PACS delivers cloud-enabled enterprise imaging experiences that are tailored to each specialty and workflow, including radiology, mammography, cardiology, pathology, and point-of-care ultrasound. The system also introduced Synapse Viewer eXtension: a native PACS application that’s centered on speed and delivers a consistent reading experience regardless of location.

"The new system is really powerful, even when compared to other vendors' PACS," states Ben Arnold, PACS System Engineer, OhioHealth.

• Synapse One: Fujifilm’s new, comprehensive, tailor-made workflow solution designed for unique outpatient imaging needs. This all-inclusive enterprise imaging solution enables providers to address everything from patient engagement, self-scheduling of exams, RIS (Radiology Information System), PACS (Picture Archiving and Communication System), advanced 3D imaging, physician portals, and more, all within the Synapse platform in the secure Amazon Web Services (AWS) cloud.

Also at RSNA, Roger Yang, MD, FACR, president of University Radiology Group (URG), will present on how to optimize AI-driven mammography workflows in PACS featuring Fujifilm’s Synapse AI Orchestrator on Tuesday, December 2 from 3:00-3:20 pm CT in South Hall-Level 3 Innovation Theater Booth #3316.

Dr. Yang will present on how his radiology network, URG, uses Fujifilm’s Synapse AI Orchestrator to optimize mammography workflows within Fujifilm’s Synapse PACS. Additionally, Dr. Yang will discuss URG’s results, the current industry architecture for delivering various AI-driven mammography findings to the PACS workstation and share real world examples on how Fujifilm’s AI Orchestrator is revolutionizing that concept by providing a common user experience, regardless of the AI engines in use, to help streamline workflows and support accurate mammography interpretations. Media that is interested in attending the presentation are kindly asked to fill out this form.

If you are attending RSNA 2025 and would like to book a demo to learn more, click here.

About Fujifilm
FUJIFILM Healthcare Americas Corporation is a comprehensive healthcare company that has an extensive range of technology and expertise in the detection, diagnosis, and treatment of diseases. Fujifilm’s innovative portfolio includes solutions spanning diagnostic imaging, enterprise imaging, endoscopic imaging, surgical imaging, and in-vitro diagnostics. The Non-Destructive Testing group delivers radiography solutions to ensure high accuracy inspection of transportation infrastructure, and assets within aerospace, and oil and gas industries.

The company is headquartered in Lexington, Massachusetts. For more information on healthcare offerings, please visit healthcaresolutions-us.fujifilm.com, and for NDT portfolio, please visit https://www.fujifilm.com/us/en/business/industrial-materials/non-destructive-testing.

FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of “giving our world more smiles,” we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen. For more information, please visit: https://holdings.fujifilm.com/en.